Risks include IV complications, allergic reactions, dosing uncertainty, and quality problems when a compounded sterile ingredient is contaminated or unsuitable for injection
The American College of Physicians and American Diabetes Association emphasize that treatment decisions should be individualized based on patient preferences, comorbidities, and clinical circumstances, with shared decision-making between patients and healthcare providers
Mindful Eating as a Tool for Diabetes Prevention and Management: A Review of Potential Mechanisms of Action
Certain foods consistently worsen GLP-1 side effects, displace more important nutrients, or undermine the metabolic outcomes you are working toward
The right choice depends on individual goals, medical history, and tolerance for injection therapy